Positive impactIPO

Tonbo Imaging India IPO Day 2: GMP of ₹500 indicates healthy potential listing premium

CNBC-TV18 1 hr ago·16 Oct 2026, 1:48 am

Tonbo Imaging India, a medical imaging firm, is in day 2 of its IPO and the book‑building process has shown a gross market price (GMP) of ₹500 per share, indicating that investors are willing to pay a premium over the issue price.

The offering is structured as an Offer For Sale, meaning the shares are being sold by existing shareholders and the company itself will not receive fresh capital. This arrangement can influence how the market perceives the company’s growth prospects and the use of any proceeds.

Investors should watch the final subscription levels, the price band that will be set before the listing, and the broader market’s reaction once the shares begin trading, as these will shape the stock’s short‑term performance.

Excerpt from CNBC-TV18

Published On Oct 16, 2026 | 07:18 IST Last Updated On Oct 16, 2026 | 07:18 IST Tonbo Imaging India's ₹852 crore IPO was fully subscribed on day one, reaching 3.99 times overall subscription. A GMP of ₹500 points to a healthy 71% listing premium. The complete Offer For Sale issue closes on October 19. The ₹852 crore…
Read the original at CNBC-TV18

Key takeaways

  • Category: IPO.
  • AI reads the tone as positive (potentially bullish) for the stock.
  • Assessed as a significant, market-relevant update.

Why it matters

A meaningful update worth tracking. The tone is positive — historically associated with upward pressure, though not predictive. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at CNBC-TV18.

More IPO news

More news

Latest headlines

More news

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.